
Opinion: Another pharma industry flip-flop: Claims about the IRA’s effect on small-molecule versus biologic drugs
The Inflation Reduction Act of 2022, which includes provisions requiring Medicare to negotiate lower drug prices for some of the United States’ most costly drugs, marks the first time in …
Read More